Cite
HARVARD Citation
Kistner, I. et al. (2016). Benefits and Risks of Aliskiren Treatment in Patients With Type 2 Diabetes: Analyses of the 3A Registry. Journal of clinical hypertension. 18 (10), pp. 1045-1053. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kistner, I. et al. (2016). Benefits and Risks of Aliskiren Treatment in Patients With Type 2 Diabetes: Analyses of the 3A Registry. Journal of clinical hypertension. 18 (10), pp. 1045-1053. [Online].